Latest pulmonary fibrosis Stories
-- Survey Data Requested by FDA for the September 26 Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis CHICAGO, Sept.
RIDGEFIELD, Conn., Sept.
For U.S. Media Only RIDGEFIELD, Conn., Sept.
Mayor Rahm Emanuel declares September Global Pulmonary Fibrosis Awareness Month in Chicago--the Pulmonary Fibrosis Foundation sponsors events to enhance disease awareness and provides patient and caregiver
-- Roche to acquire InterMune for $74.00 per share -- BASEL, Switzerland, Aug. 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc.
New data will be reported to FDA at patient-focused drug development meeting on 9/26; insights will help future PFF programs and services CHICAGO, Aug.
MORRISTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Moerae Matrix, Inc.
Patients, caregivers and health care professionals share stories; offer awareness, hope and inspiration CHICAGO, July 23, 2014 /PRNewswire-USNewswire/ -- Twenty of the Pulmonary Fibrosis
Nintedanib and Pirfenidone Received Breakthrough Therapy Designation by the U.S.
For U.S. Media Only RIDGEFIELD, Conn., July 16, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S.
- To fire mitraille at.